Crinetics Pharmaceuticals Inc. (CRNX)
Market Closed
1 Sep, 08:00 PM
$
84. 95
0
0%
Pre Market
$
0 0% 84. 95
9.01B Market Cap
- P/E Ratio
- Div Yield
8.18M Volume
-3.64 Eps
$ 84.95
Previous Close 
Want to track CRNX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crinetics Pharmaceuticals Inc. (CRNX) Statistics
Valuation metrics
Market Cap 9.01B
Enterprise value 8.99B
Trailing P/E (ttm) -16.82
Forward P/E -8.81
PEG ratio 0.83
Price/Sales (ttm) 213.54
Price/Book (mrq) 7.52
Enterprise Value/Revenue 213.34
Enterprise Value/EBITDA -17.68
Overview
Shares outstanding 95.58M
Float 96.99M
Shares short 14.17M
% Held by insiders 0.02%
% Held by institutions 1.11%
Average volume (10 days) 4.86M
Average volume (90 days) 3.09M
Price summary
52-Week low 32.3
52-Week high 85.01
Beta 0.28
50-Day moving average 84.91
200-Day moving average 44.6
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -11.9%
Operating margin -13.03%
Operational effectiveness
Return on assets -0.38%
Return on equity -0.44%
Income Statement
Revenue (ttm) 18.07M
Revenue per share (ttm) 0.4
Quarterly revenue growth (yoy) 28.73%
Gross profit (ttm) -339.11M
EBITDA -541.62M
Net income to common (ttm) -496.39M
Diluted EPS (ttm) -4.75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.29B
Total cash per share (mrq) 11.42
Total debt (mrq) 47.85M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 15.57%
Book value per share (mrq) 11.29
Cash Flow
Cash flow statement -414.17M
Levered free cash flow (LFCF) -242.14M
2026 © Marketlog. All Rights Reserved.
